In a news conference held on May 5, Maryland Governor Martin O’Malley announced that the Institute of Human Virology (IHV) at the University of Maryland received funding from a consortium to collaborate on a promising new HIV vaccine.
A collaborative program between MHRP’s site in Tanzania and WRAIR’s malaria program is building capacity and infrastructure within Tanzania to strengthen malaria diagnostic capabilities.
MHRP’s molecular epidemiologists played a key role on a research team that analyzed the HIV-1 genome sequences from infected volunteers in the Step HIV vaccine trial.
In Southwestern Tanzania, just steps from the Malawi border lies the bustling port town of Kyela, one of eight districts in the Mbeya region. A bustling commercial hub, Kyela endures an HIV prevalence rate well above the national average, which leaves a s
MHRP scientists identified three effective and non-proprietary adjuvants that proved safe and more potent than a widely used adjuvant in commercial vaccines.
Eight U.S. Public Health Service (PHS) officers were deployed to MHRP’s site in Lagos, Nigeria to participate in a malaria diagnostics and laboratory capacity building training exercise. This program provided hands-on education and practical experience in
